Alerts will be sent to your verified email
Verify EmailCHECKPOINT
Rubra Medicaments
|
Vaxfab Enterprise
|
Laffans Petrochem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-2.03 % | -8.32 % | 2.26 % |
5yr average Equity Multiplier
|
1.44 | 1.33 | 1.08 |
5yr Average Asset Turnover Ratio
|
1.44 | 0.41 | 0.22 |
5yr Avg Net Profit Margin
|
-0.31 % | -11.8 % | 16.84 % |
Price to Book
|
50.18 | 1.7 | 0.42 |
P/E
|
318.39 | 71.7 | 8.9 |
5yr Avg Cash Conversion Cycle
|
183.71 Days | -19.53 Days | -1.42 Days |
Inventory Days
|
0.0 | 121.42 Days | 11.96 Days |
Days Receivable
|
183.71 Days | 158.29 Days | 0.21 Days |
Days Payable
|
33.56 Days | 130.94 Days | 39.09 Days |
5yr Average Interest Coverage Ratio
|
-248.31 | 45.42 | 29.48 |
5yr Avg ROCE
|
-2.28 % | 1.4 % | 3.75 % |
5yr Avg Operating Profit Margin
|
-0.3 % | -9.6 % | -29.01 % |
5 yr average Debt to Equity
|
0.06 | 0.01 | 0.01 |
5yr CAGR Net Profit
|
0.0 | n/a | -9.69 % |
5yr Average Return on Assets
|
-1.63 % | -6.15 % | 2.06 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 0.0 | 57.32 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.78 % | 1.95 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Rubra Medicaments
|
Vaxfab Enterprise
|
Laffans Petrochem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|